SNS 기사보내기
Novo Nordisk Korea said Thursday it has signed a memorandum of understanding (MOU) with the Seoul Metropolitan Government, the Korean Diabetes Association, the Korean Society for the Study of Obesity, and the Embassy of Denmark in Korea, as part of “Cities for Better Health,” a global partnership project aimed at enhancing health equity in urban communities.
The signing ceremony was attended by Kasper Roseeuw Poulsen, General Manager of Novo Nordisk Korea, Kim Tae-hee, Director of Public Health at the Seoul Metropolitan Government, Cha Bong-soo, Chairman of the Korean Diabetes Association, Kim Min-seon, President of the Korean Society for the Study of Obesity, and Philip Alexander Hallqvist, Deputy Head of Mission, Embassy of Denmark in Korea.
From left: Cha Bong-soo, chairman of the Korean Diabetes Association; Kasper Roseeuw Poulsen, General Manager of Novo Nordisk Korea; Kim Tae-hee, Director of Public Health at the Seoul Metropolitan Government; Philip Alexander Hallqvist, Deputy Head of Mission, Embassy of Denmark in Korea; and Kim Min-seon, President of the Korean Society for the Study of Obesity. (Courtesy of Novo Nordisk Korea)
From left: Cha Bong-soo, chairman of the Korean Diabetes Association; Kasper Roseeuw Poulsen, General Manager of Novo Nordisk Korea; Kim Tae-hee, Director of Public Health at the Seoul Metropolitan Government; Philip Alexander Hallqvist, Deputy Head of Mission, Embassy of Denmark in Korea; and Kim Min-seon, President of the Korean Society for the Study of Obesity. (Courtesy of Novo Nordisk Korea)
The agreement aims to enhance health equity for Seoul's citizens and support joint programs to strengthen the city's chronic disease management ecosystem. All parties recognize that the societal burden of chronic diseases is rising worldwide. In response, they emphasize the shared responsibility of both the public and private sectors to create healthy urban environments—where people are born, grow, work, and age—to address common risk factors for chronic diseases.
"Based on our experience in 51 cities worldwide, Novo Nordisk is dedicated to contributing to the development of a sustainable ecosystem that enhances health equity for Seoul's citizens," said Poulsen, GM of Novo Nordisk Korea.
Director Kim from the Seoul government emphasized that improving the health of Seoul’s 10 million citizens is a top policy priority.
He expressed hope that the Cities for Better Health project would serve as a turning point in the city's efforts to become more inclusive and health-focused.
“Through this partnership, Seoul plans to redesign living environments for vulnerable populations and implement policies aimed at enhancing health equity,” he said.
According to Chairman Cha of the Korean Diabetes Association, the prevalence of diabetes among Koreans aged 65 and older has nearly doubled over the past decade, with more than half (53.8 percent) of those affected also experiencing obesity.
President Kim from the Korean Society for the Study of Obesity noted that four in 10 Korean adults were obese, which was not only a health issue but also a socioeconomic challenge.
“Our obesity society will contribute to the creation of a healthy urban environment in Seoul by presenting obesity prevention and management strategies based on scientific evidence,” she said.
Halkvist, Deputy Head of Mission, Embassy of Denmark in Korea, said “Through our Cities for Better Health, Novo Nordisk has worked with major cities around the world, including the City of Copenhagen, to significantly improve the quality of life for their citizens by focusing on creating healthier living environments.”
“Building on our successful experience in Copenhagen, we hope that this collaboration with Seoul will mark a new milestone in the creation of healthy cities in Asia.”
The Cities for Better Health project is being implemented in 51 cities around the world with the goal of creating sustainable and healthy cities by addressing disparities in health equity for city residents through multi-sectoral public and private collaboration.
tweet
Related articles
Novo Nordisk Korea appoints Poulsen as new GM
Korean doctors say obesity treatment matters—so why aren’t they prescribing?
Wegovy’s success in Korea hinges on tackling misuse and cost barriers: experts
Novo Nordisk Korea signs MOU with SNUBH to advance future medical technologies
Kim Yoon-mi yoonmi@docdocdoc.co.kr
See Other Articles
Copyright © KBR Unauthorized reproduction, redistribution prohibited